Dec 16 (Reuters) - Novartis AG NOVN.S :
* NOVARTIS PHARMACEUTICALS CANADA INC - HEALTH CANADA APPROVED ZOLGENSMA FOR TREATMENT OF PEDIATRIC PATIENTS WITH 5Q SPINAL MUSCULAR ATROPHY (SMA)1
Dec 16 (Reuters) - Novartis AG NOVN.S :
* NOVARTIS PHARMACEUTICALS CANADA INC - HEALTH CANADA APPROVED ZOLGENSMA FOR TREATMENT OF PEDIATRIC PATIENTS WITH 5Q SPINAL MUSCULAR ATROPHY (SMA)1